Condition
Post-acne Hyperpigmentation
Total Trials
2
Recruiting
0
Active
0
Completed
0
Key Insights
Highlights
Treatment Research
3 treatments under study, led by A Combination Serum Containing Melasyl 10 Niacinamide Hyaluronic Acid And Hepes
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 2 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
2Total
Not Applicable (2)
Trial Status
Not Yet Recruiting2
Clinical Trials (2)
Showing 2 of 2 trials
NCT07896486Not ApplicableNot Yet Recruiting
Evaluating a Brightening Serum for Post-Inflammatory Hyperpigmentation
NCT07121439Not ApplicableNot Yet Recruiting
Efficacy and Safety of a Combined Serum Containing Melasyl™, 10% Niacinamide, Hyaluronic Acid, and HEPES
Showing all 2 trials
Research Network
Common Treatments
- A Combination Serum Containing Melasyl 10 Niacinamide Hyaluronic Acid And Hepes1
- Vinoperfect Brightening Serum1
- Hydroquinone1
Active Sponsors
- Caudalie1
- Dr.dr.Irma Bernadette, SpKK (K)1
- Weill Medical College of Cornell University1
Top Investigators
Weill Medical College of Cornell University
Related Conditions
- Melasma1
- Postinflammatory Hyperpigmentation1